Abstract

3Qualitas, Danworth Lane, Hurstpierpoint, West Sussex BN6 9LN, UK; 4Institute for In Vitro Science, 21 Firstfield Road, Suite 220, Gaithersburg, MD 20878, USA; 5ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, 21020 Ispra (VA), Italy; 6Charles University Faculty of Medicine, Simkova 870, Hradec Kralove, Czech Republic; 7FRAME Alternatives Laboratory, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham NG7 2UH, UK; 8RCC Cytotest Cell Research, In den Leppsteinwiessen 19, 64380 Rossdorf, Germany; 9Human and Environmental Safety Division, The Procter and Gamble Company, Cincinnati, OH, USA; 10ZEBET, BgVV, Diedersdorfer Weg 1, 12277 Berlin, Germany; 11Genetic and In Vitro Toxicology, Janssen Pharmaceutica, Turnhoutse Weg 30, 2340 Beerse, Belgium ATLA 27, 539–577, 1999 539

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call